174 related articles for article (PubMed ID: 27125569)
1. Mechanistic studies of new oximes reactivators of human butyryl cholinesterase inhibited by cyclosarin and sarin.
de Lima WE; Francisco A; da Cunha EF; Radic Z; Taylor P; França TC; Ramalho TC
J Biomol Struct Dyn; 2017 May; 35(6):1272-1282. PubMed ID: 27125569
[TBL] [Abstract][Full Text] [Related]
2. New Heterostilbene and Triazole Oximes as Potential CNS-Active and Cholinesterase-Targeted Therapeutics.
Mlakić M; Čadež T; Šinko G; Škorić I; Kovarik Z
Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927082
[TBL] [Abstract][Full Text] [Related]
3. Reactivation kinetics of 31 structurally different bispyridinium oximes with organophosphate-inhibited human butyrylcholinesterase.
Horn G; Wille T; Musilek K; Kuca K; Thiermann H; Worek F
Arch Toxicol; 2015 Mar; 89(3):405-14. PubMed ID: 24912784
[TBL] [Abstract][Full Text] [Related]
4. Pseudo-catalytic scavenging: searching for a suitable reactivator of phosphorylated butyrylcholinesterase.
Kovarik Z; Katalinić M; Sinko G; Binder J; Holas O; Jung YS; Musilova L; Jun D; Kuca K
Chem Biol Interact; 2010 Sep; 187(1-3):167-71. PubMed ID: 20206154
[TBL] [Abstract][Full Text] [Related]
5. Reactivation kinetics of a homologous series of bispyridinium bis-oximes with nerve agent-inhibited human acetylcholinesterase.
Worek F; von der Wellen J; Musilek K; Kuca K; Thiermann H
Arch Toxicol; 2012 Sep; 86(9):1379-86. PubMed ID: 22437842
[TBL] [Abstract][Full Text] [Related]
6. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
7. Butyrylcholinesterase inhibited by nerve agents is efficiently reactivated with chlorinated pyridinium oximes.
Zorbaz T; Malinak D; Kuca K; Musilek K; Kovarik Z
Chem Biol Interact; 2019 Jul; 307():16-20. PubMed ID: 31004594
[TBL] [Abstract][Full Text] [Related]
8. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F
Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433
[TBL] [Abstract][Full Text] [Related]
9. Molecular Modeling Studies on the Multistep Reactivation Process of Organophosphate-Inhibited Acetylcholinesterase and Butyrylcholinesterase.
Jończyk J; Kukułowicz J; Łątka K; Malawska B; Jung YS; Musilek K; Bajda M
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33513955
[TBL] [Abstract][Full Text] [Related]
10. Effect of reversible ligands on oxime-induced reactivation of sarin- and cyclosarin-inhibited human acetylcholinesterase.
Scheffel C; Thiermann H; Worek F
Toxicol Lett; 2015 Feb; 232(3):557-65. PubMed ID: 25522658
[TBL] [Abstract][Full Text] [Related]
11. Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches.
Mangas I; Taylor P; Vilanova E; Estévez J; França TC; Komives E; Radić Z
Arch Toxicol; 2016 Mar; 90(3):603-16. PubMed ID: 25743373
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol Oxime Olesoxime Assessed as a Potential Ligand of Human Cholinesterases.
Kolić D; Šinko G; Jean L; Chioua M; Dias J; Marco-Contelles J; Kovarik Z
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785995
[TBL] [Abstract][Full Text] [Related]
13. Halogen substituents enhance oxime nucleophilicity for reactivation of cholinesterases inhibited by nerve agents.
Zorbaz T; Malinak D; Hofmanova T; Maraković N; Žunec S; Hrvat NM; Andrys R; Psotka M; Zandona A; Svobodova J; Prchal L; Fingler S; Katalinić M; Kovarik Z; Musilek K
Eur J Med Chem; 2022 Aug; 238():114377. PubMed ID: 35526478
[TBL] [Abstract][Full Text] [Related]
14. Exploring the physicochemical properties of oxime-reactivation therapeutics for cyclosarin, sarin, tabun, and VX inactivated acetylcholinesterase.
Esposito EX; Stouch TR; Wymore T; Madura JD
Chem Res Toxicol; 2014 Jan; 27(1):99-110. PubMed ID: 24443939
[TBL] [Abstract][Full Text] [Related]
15. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
Maxwell DM; Brecht KM; Sweeney RE
Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
[TBL] [Abstract][Full Text] [Related]
16. Enantioseparation, in vitro testing, and structural characterization of triple-binding reactivators of organophosphate-inhibited cholinesterases.
Maraković N; Knežević A; Rončević I; Brazzolotto X; Kovarik Z; Šinko G
Biochem J; 2020 Aug; 477(15):2771-2790. PubMed ID: 32639532
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of organophosphate-inhibited serum butyrylcholinesterase by novel substituted phenoxyalkyl pyridinium oximes and traditional oximes.
Nichols RH; Chambers JE
Toxicology; 2021 Mar; 452():152719. PubMed ID: 33592259
[TBL] [Abstract][Full Text] [Related]
18. Direct reaction of oximes with crotylsarin, cyclosarin, or VX in vitro.
Becker G; Kawan A; Gutzeit D; Worek F; Szinicz L
Arch Toxicol; 2007 Jun; 81(6):415-20. PubMed ID: 17151865
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J
Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of structural homoloques and isomers of pralidoxime in reactivation of immobilised acetylcholinesterase inhibited with sarin, cyclosarin and soman.
Hoskovcova M; Halamek E; Kobliha Z
Neuro Endocrinol Lett; 2009; 30 Suppl 1():152-5. PubMed ID: 20027163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
